United Therapeutics Corporation
UTHR
NASDAQ·Healthcare·Biotechnology·Mkt cap $20.7B
$487.61
▼ -0.54%
P/E
16.84
Mkt Cap
$20.7B
52-Wk Range
$388.73–$609.35
52-Week Range
$388.73 - $609.35
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 23.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized rare disease focus
- Comprehensive PAH treatment portfolio
- Advanced R&D pipeline
- Targeted therapeutic innovations
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Expanding PAH treatment market
Value
Attractively priced below Biotech & Therapeutics peer average
Momentum
Weak
-10.5% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying UTHR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $7.27 vs $6.86 consensus (+6.0% surprise). Revenue of $783.3M vs $804.6M expected (-2.6%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+6.0%
Revenue trend · last 8Q
—
+20%
+17%
+12%
+7%
+7%
-2%
-2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$748.9M
$735.9M
$794.4M
$798.6M
$799.5M
$790.2M
$781.5M
$783.3M
Margins · last 8Q
Gross
87.3%
Operating
42.2%
Profit
42.5%
Wall Street consensus
6 analysts · 67% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
67%
Hold
33%
Sell
0%
Median Price Target
—
Latest: RBC Capital · May 7, 2026
vs Industry
How UTHR stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related